netFormulary NHS
NHS Herefordshire Clinical Commissioning Group
Wye Valley NHS Trust
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
08.01.05  Expand sub section  Other antineoplastic drugs
Alectinib (Alecensa®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
NHS England

Oral cancer drug NHSE commissioned

 
   
Cabozantinib (Cabometyx®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Oral cancer drug (NHSE commissioned)

 

 
   
Ceritinib (Zykadia)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
NHS England

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA395: Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer
Link  NICE TA500: Ceritinib for untreated ALK-positive non-small-cell lung cancer
   
Ibrutinib (Imbruvica®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
NHS England

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA429 : Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
Link  NICE TA491: Ibrutinib for treating Waldenstrom’s macroglobulinaemia
Link  NICE TA502: Ibrutinib for treating relapsed or refractory mantle cell lymphoma
   
Ixazomib (Ninlaro®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
NHS England

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA505: Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma
   
Lenvatinib (Lenvima®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
NHS England

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA498: Lenvatinib with everolimus for previously treated advanced renal cell carcinoma
   
Venetoclax (Venclyxto®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
Cancer Drugs Fund

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA487: Venetoclax for treating chronic lymphocytic leukaemia
   
08.01.05  Expand sub section  Amsacrine
08.01.05  Expand sub section  Arsenic trioxide
08.01.05  Expand sub section  Bevacizumab
08.01.05  Expand sub section  Bexarotene to top
08.01.05  Expand sub section  Bortezomib
Cytotoxic Drug Bortezomib (Velcade®)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA129: Multiple myeloma - bortezomib
Link  NICE TA228: 1st line treatment of multiple myeloma
Link  NICE TA311: Bortezomib for induction therapy in multiple myeloma
Link  NICE TA370: Bortezomib for previously untreated mantle cell lymphoma
   
08.01.05  Expand sub section  Brentuximab vedotin
08.01.05  Expand sub section  Cetuximab
08.01.05  Expand sub section  Crisantaspase
08.01.05  Expand sub section  Dacarbazine and Temozolomide to top
Cytotoxic Drug Dacarbazine
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
   
Cytotoxic Drug Temozolomide (Temodal®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
 
Link  NICE TA121: Glioma (newly diagnosed and high grade)
Link  NICE TA23: Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)
   
08.01.05  Expand sub section  Erlotinib
Erlotinib (Tarceva® )
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
NHS England

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA227: Lung cancer (non-small-cell) maintenance - erlotinib
Link  NICE TA258: Lung cancer (non-small-cell) 1st line- erlotinib
Link  NICE TA374: Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
   
08.01.05  Expand sub section  Hydroxycarbamide
Cytotoxic Drug Hydroxycarbamide
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Amber

Haematology - see shared care

 

 
Link  Shared Care
   
08.01.05  Expand sub section  Imatinab
08.01.05  Expand sub section  Ipilimumab
08.01.05  Expand sub section  Mitotane to top
08.01.05  Expand sub section  Panitumumab
08.01.05  Expand sub section  Pentostatin
08.01.05  Expand sub section  Platinum compounds
Cytotoxic Drug Carboplatin
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
   
Carboplatin (Paraplatin®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
   
Cytotoxic Drug Cisplatin
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
   
Cytotoxic Drug Oxaliplatin
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

To be used in accordance with NICE guidance

 
Link  NICE TA100: Colon cancer (adjuvant) - capecitabine and oxaliplatin
   
Oxaliplatin (Eloxatin®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

To be used in accordance with NICE guidance

 
   
08.01.05  Expand sub section  Porfimer sodium and temoporfin
08.01.05  Expand sub section  Procarbazine to top
Cytotoxic Drug Procarbazine
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

Oral cancer drug (NHSE commissioned)

 

 
   
08.01.05  Expand sub section  Protein kinase inhibitors
Cabozantinib (Cometriq®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
Cancer Drugs Fund

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA463 : Cabozantinib for previously treated advanced renal cell carcinoma
Link  NICE TA516: Cabozantinib for treating medullary thyroid cancer
   
Dasatinib (Sprycel®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
Cancer Drugs Fund
NHS England

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA241: CML where treatment with imatinib has failed
Link  NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia
Link  NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia
   
Erlotinib (Tarceva®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
NHS England

Oral cancer drug (NHSE commissioned)

 

 
   
Gefitinib (Iressa®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
NHS England

Oral cancer drug (NHSE commissioned)

 
Link  NICE TA192: Lung cancer (non-small-cell, first line) - gefitinib
Link  NICE TA374: Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
   
Cytotoxic Drug Imatinib (Gilvec®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
NHS England

 Restricted: NICE approved for CML (philidephia chromosome + ve)

 
   
Nilotinib (Tasigna®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine

Oral cancer drug (NHSE commissioned)

 

 
Link  NICE TA241: Dasatinib, nilotinib and high dose imatinib for CML
Link  NICE TA251: Dasatinib, nilotinib and imatinib for first line treatment of CML
Link  NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia
Link  NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia
   
Regorafenib (Stivarga® )
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
Cancer Drugs Fund
 
Link  NICE TA488: Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours
Link  NICE TA514: Regorafenib for previously treated advanced hepatocellular carcinoma
   
Sorafenib (Nexavar®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
Cancer Drugs Fund

Oral cancer drug NHSE commissioned

 
Link  NICE TA474: Sorafenib for treating advanced hepatocellular carcinoma
   
Sunitinib (Sutent®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
Cancer Drugs Fund

Oral cancer drug (NHSE commissioned)

 
Link  NICE TA169: Renal cell carcinoma - sunitinib
Link  NICE TA179: Gastrointestinal stromal tumours - sunitinib
Link  NICE TA449 : Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease
   
Tivozanib
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

Oral cancer drug (NHSE commissioned)

 
Link  NICE TA512: Tivozanib for treating advanced renal cell carcinoma
   
08.01.05  Expand sub section  Taxanes
Cytotoxic Drug Docetaxel (Taxotere®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
Link  NICE TA101: Prostate cancer (hormone-refractory) - docetaxel
Link  NICE TA109: Breast cancer (early) - docetaxel
   
Cytotoxic Drug Paclitaxel
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
Link  NICE TA108: Breast cancer (early) - paclitaxel
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
Link  NICE TA476: Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer
   
Paclitaxel (Abraxane®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
   
Paclitaxel (Taxol®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
   
08.01.05  Expand sub section  Topoisomerase I inhibitors
Cytotoxic Drug Irinotecan Hydrochloride
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
   
08.01.05  Expand sub section  Trabectedin
08.01.05  Expand sub section  Trastuzumab to top
Cytotoxic Drug Trastuzumab (Herceptin®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red

Herceptin® – to be used in accordance with NICE guidance

 
Link  NICE TA208: Gastric cancer (HER2-positive metastatic) - trastuzumab
Link  NICE TA257: in combination with an aromatase inhibitor for HER2 positive metastatic breast cancer
Link  NICE TA34: Breast cancer - trastuzumab
   
08.01.05  Expand sub section  Tretinoin
08.01.05  Expand sub section  Vismodegib
 ....
 Non Formulary Items
Afatinib  (Giotrif®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA310: Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer
 
Cytotoxic Drug  Aflibercept  (Zaltrap®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy
 
Cytotoxic Drug  Amsacrine  (Amsidine®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cytotoxic Drug  Arsenic Trioxide  (Trisenox®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA526: Arsenic trioxide for treating acute promyelocytic leukaemia
 
Atezolizumab  (Tecentriq®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA492: Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable
Link  NICE TA520 : Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy
Link  NICE TA525: Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
 
Avelumab

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA517: Avelumab for treating metastatic Merkel cell carcinoma
 
Axitinib  (Inlyta®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA333: Axitinib for advanced renal cell carcinoma
 
Bevacizumab  (Avastin®)
(Oncology)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA214: Breast Cancer with taxane
Link  NICE TA263: Breast cancer with capecitabine
Link  NICE TA285: Ovarian, fallopian tube and primary peritoneal cancer (recurrent advanced, platinum-sensitive or partially platinum-sensitive) - bevacizumab
 
Bexarotene  (Targretin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Bosutinib  (Bosulif®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA401: Bosutinib for previously treated chronic myeloid leukaemia
 
Brentuximab vedotin  (Adcetris®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA446 : Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma
Link  NICE TA478L Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma
Link  NICE TA524: Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma
 
Cytotoxic Drug  Cabazitaxel  (Jevtana®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA391: Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel
 
Carfilzomib  (Kyprolis®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA457 : Carfilzomib for previously treated multiple myeloma
 
Cetuximab  (Erbitux®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA145: Head and neck cancer - cetuximab
Link  NICE TA176: Colorectal cancer (first line) - cetuximab
Link  NICE TA439 : Cetuximab and panitumumab for previously untreated metastatic colorectal cancer
Link  NICE TA473: Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck
 
Crisantaspase  (Erwinase®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Crizotinib  (Xalkori®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA406: Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
Link  NICE TA422: Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cance
Link  NICE TA529: Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer
 
Dabrafenib  (Tafinlar®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA321:Dabrafenib for BRAF V600 +ve melanoma
Link  NICE TA396:Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma
 
Daratumumab  (Darzalex®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA510: Daratumumab monotherapy for treating relapsed and refractory multiple myeloma
 
Elotuzumab  (Empliciti®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cytotoxic Drug  Eribulin  (Halaven®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA423: Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens
Link  NICE TA515: Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen
 
Everolimus  (Afinitor®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA348: Preventing Rejection in Liver Transplant
Link  NICE TA421: Everolimus with exemestane for treating advanced breast cancer after endocrine therapy
Link  NICE TA449 : Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease
 
Everolimus  (Votubia®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA449 : Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease
 
Idelalisib  (Zydelig®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA359: Chronic lymphocytic leukaemia - Idelalisib
 
Ipilimumab  (Yervoy®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA268: Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma
Link  NICE TA319: Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma
Link  NICE TA400: Nivolumab in combination with ipilimumab for treating advanced melanoma
 
Cytotoxic Drug  Irinotecan hydrochloride trihydrate  (Onivyde®)
(pegylated liposomal)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lapatinib  (Tyverb®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA257: in combination with an aromatase inhibitor for HER2 positive metastatic breast cancer
 
Midostaurin

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA523: Midostaurin for untreated acute myeloid leukaemia
 
Mitotane  (Lysodren®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Necitumumab  (Portrazza®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA411: Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer
 
Olaratumab  (Lartruvo®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
 
Pablociclib  (Ibrance®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cytotoxic Drug  Paclitaxel - Albumin Bound Formulation  (Abraxane®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA360: Pancreatic cancer - paclitaxel with gemcitabine
 
Cytotoxic Drug  Panitumumab  (Vectibix®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA439 : Cetuximab and panitumumab for previously untreated metastatic colorectal cancer
 
Cytotoxic Drug  Panobinostat  (Farydak®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA380: Panobinostat for treating multiple myeloma after at least 2 previous treatments
 
Pazopanib  (Votrient®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA215: Pazopanib in renal cell cancer
 
Pembrolizumab  (Keytruda®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA357: Pembrolizumab for melanoma after ipilimumab
Link  NICE TA366: Pembrolizumab for advanced melanoma not previously treated with ipilimumab
Link  NICE TA428: Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy
Link  NICE TA447 : Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer
Link  NICE TA519: Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
Link  NICE TA522: Pembrolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable
 
Cytotoxic Drug  Pentostatin  (Nipent®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cytotoxic Drug  Pertuzumab  (Perjeta®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA424: Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer
Link  NICE TA509: Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer
 
Ponatinib  (Iclusig®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA451 : Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia
 
Porfimer Sodium  (Photofrin ®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ramucirumab  (Cyramza®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA403: Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer
 
Rociletinib

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ruxolitinib  (Jakavi®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA386: Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis
 
Sonidegib  (Odomzo®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cytotoxic Drug  Talimogene laherparepvec  (Imlygic®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA410: Talimogene laherparepvec for treating unresectable metastatic melanoma
 
Temoporfin  (Foscan®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Cytotoxic Drug  Temsirolimus  (Torisel®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
 
Cytotoxic Drug  Topotecan  (Hycamtin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA183: Cervical cancer (recurrent) - topotecan
Link  NICE TA184: Lung cancer (small-cell) - topotecan
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
 
Cytotoxic Drug  Trabectedin  (Yondelis®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Link  NICE TA185: Soft tissue sarcoma - trabectedin
Link  NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer
 
Trametinib  (Mekinist®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA396: Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma
 
Cytotoxic Drug  Trastuzumab emtansine  (Kadcyla®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Cancer Drugs Fund
Link  NICE TA458 : Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxan
 
Tretinoin  (Vesanoid®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Trifluridine-tipiracil  (Lonsurf®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
 
Cytotoxic Drug  Vandetanib  (Caprelsa®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
 
Vemurafenib  (Zelboraf®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Link  NICE TA269: Vemurafenib for treating malignant melanoma
 
Cytotoxic Drug  Vismodegib  (Erivedge®)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
Cancer Drugs Fund
Link  NICE TA489: Vismodegib for treating basal cell carcinoma
 
Vosaroxin  (Qinprezo)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Suitable for use in primary care  

Amber

Specialist initiation. Shared care in place  

Red

Red do not use..  

Advice

Some formulations restricted  

Black

NICE "Do not do"  

Green 1

1st line option  

Green 2

2nd line option  

Green 3

3rd line option only  

Not Recomended / Black

Low Value Medicine not recommended for use - see NHSE guidelines  

OTC

This preparation should be bought over the counter for self-care  

Red Amber

Check product description for traffic light status  

Red Black

Low Value Medicine  

netFormulary